Identification of Adropin as a Secreted Factor Linking Dietary Macronutrient Intake with Energy Homeostasis and Lipid Metabolism

Cell Metabolism

Volumn 8, Issue 6, 2008, Pages 468-481

  Kumar, K Ganesh ^a   Trevaskis, James L ^a   Lam, Daniel D ^b   Sutton, Gregory M ^a   Koza, Robert A ^a   Chouljenko, Vladimir N ^c   Kousoulas, Konstantin G ^c   Rogers, Pamela M ^a   Kesterson, Robert A ^d   Thearle, Marie ^e   Ferrante Jr , Anthony W ^e   Mynatt, Randall L ^a   Burris, Thomas P ^a   Dong, Jesse Z ^f   Halem, Heather A ^f   Culler, Michael D ^f   Heisler, Lora K ^b   Stephens, Jacqueline M ^g   Butler, Andrew A ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c LOUISIANA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e NewYork Presbyterian Hospital   (United States)

^f Biomeasure Inc   (United States)

^g LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

HUMDISEASE

Indexed keywords

ADROPIN; ADROPIN[34-76]; ENERGY HOMEOSTASIS ASSOCIATED PROTEIN; LIVER PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SYNTHETIC PEPTIDE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; C57BL 6 MOUSE; CONTROLLED STUDY; DIET RESTRICTION; DIETARY INTAKE; DRUG DOSE COMPARISON; ENERGY BALANCE; ENERGY METABOLISM; FATTY LIVER; FEMALE; FOOD INTAKE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GLUCOSE HOMEOSTASIS; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; LIPID METABOLISM; LIPOGENESIS; LIVER; MACRONUTRIENT; MALE; METABOLIC DISORDER; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; TRANSGENICS;

ADIPOSE TISSUE, BROWN; ADIPOSE TISSUE, WHITE; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BENZOIC ACIDS; BENZYLAMINES; CELLS, CULTURED; DNA-BINDING PROTEINS; ENERGY METABOLISM; FASTING; FATTY LIVER; FEMALE; HUMANS; LEPTIN; LIPID METABOLISM; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; OBESITY; PROTEINS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING;

MUS;

EID: 56449125471     PISSN: 15504131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmet.2008.10.011     Document Type: Article

References (38)

1. Asilmaz E., Cohen P., Miyazaki M., Dobrzyn P., Ueki K., Fayzikhodjaeva G., Soukas A.A., Kahn C.R., Ntambi J.M., Socci N.D., et al. Site and mechanism of leptin action in a rodent form of congenital lipodystrophy. J. Clin. Invest. 113 (2004) 414-424
2. Biddinger S.B., and Kahn C.R. From mice to men: insights into the insulin resistance syndromes. Annu. Rev. Physiol. 68 (2006) 123-158
3. Butler A.A. The melanocortin system and energy balance. Peptides 27 (2006) 281-290
4. Cannon B., and Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol. Rev. 84 (2004) 277-359
5. Cowie C.C., Rust K.F., Byrd-Holt D.D., Eberhardt M.S., Flegal K.M., Engelgau M.M., Saydah S.H., Williams D.E., Geiss L.S., and Gregg E.W. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002. Diabetes Care 29 (2006) 1263-1268
6. Denechaud P.D., Bossard P., Lobaccaro J.M., Millatt L., Staels B., Girard J., and Postic C. ChREBP, but not LXRs, is required for the induction of glucose-regulated genes in mouse liver. J. Clin. Invest. 118 (2008) 956-964
7. Emanuelsson O., Brunak S., von Heijne G., and Nielsen H. Locating proteins in the cell using TargetP, SignalP and related tools. Nat. Protocols 2 (2007) 953-971
8. Flier J.S. Obesity wars. Molecular progress confronts an expanding epidemic. Cell 116 (2004) 337-350
9. Floyd Z.E., and Stephens J.M. Interferon-gamma-mediated activation and ubiquitin-proteasome-dependent degradation of PPARgamma in adipocytes. J. Biol. Chem. 277 (2002) 4062-4068
10. Goodwin B., Jones S.A., Price R.R., Watson M.A., McKee D.D., Moore L.B., Galardi C., Wilson J.G., Lewis M.C., Roth M.E., et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol. Cell 6 (2000) 517-526
11. Heilbronn L.K., Gregersen S., Shirkhedkar D., Hu D., and Campbell L.V. Impaired fat oxidation after a single high-fat meal in insulin-sensitive nondiabetic individuals with a family history of type 2 diabetes. Diabetes 56 (2007) 2046-2053
12. Heisler L.K., Jobst E.E., Sutton G.M., Zhou L., Borok E., Thornton-Jones Z., Liu H.Y., Zigman J.M., Balthasar N., Kishi T., et al. Serotonin reciprocally regulates melanocortin neurons to modulate food intake. Neuron 51 (2006) 239-249
13. Hill J.O. Understanding and addressing the epidemic of obesity: an energy balance perspective. Endocr. Rev. 27 (2006) 750-761
14. Horton J.D., Goldstein J.L., and Brown M.S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109 (2002) 1125-1131
15. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 444 (2006) 860-867
16. Kalaany N.Y., and Mangelsdorf D.J. LXRS and FXR: the yin and yang of cholesterol and fat metabolism. Annu. Rev. Physiol. 68 (2006) 159-191
17. Kim J.Y., van de Wall E., Laplante M., Azzara A., Trujillo M.E., Hofmann S.M., Schraw T., Durand J.L., Li H., Li G., et al. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J. Clin. Invest. 117 (2007) 2621-2637
18. Koza R.A., Nikonova L., Hogan J., Rim J.S., Mendoza T., Faulk C., Skaf J., and Kozak L.P. Changes in gene expression foreshadow diet-induced obesity in genetically identical mice. PLoS Genet. 2 (2006) e81
19. Laffitte B.A., Joseph S.B., Chen M., Castrillo A., Repa J., Wilpitz D., Mangelsdorf D., and Tontonoz P. The phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesions. Mol. Cell. Biol. 23 (2003) 2182-2191
20. LeRoith D., and Yakar S. Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1. Nat. Clin. Pract. Endocrinol. Metab. 3 (2007) 302-310
21. Mitro N., Mak P.A., Vargas L., Godio C., Hampton E., Molteni V., Kreusch A., and Saez E. The nuclear receptor LXR is a glucose sensor. Nature 445 (2007) 219-223
22. Moraes M.P., Mayr G.A., and Grubman M.J. pAd5-Blue: direct ligation system for engineering recombinant adenovirus constructs. Biotechniques 31 (2001) 1050, 1052, 1054-1056
23. Morino K., Petersen K.F., and Shulman G.I. Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction. Diabetes 55 Suppl 2 (2006) S9-S15
24. Morton G.J., Cummings D.E., Baskin D.G., Barsh G.S., and Schwartz M.W. Central nervous system control of food intake and body weight. Nature 443 (2006) 289-295
25. Nogueiras R., Wiedmer P., Perez-Tilve D., Veyrat-Durebex C., Keogh J.M., Sutton G.M., Pfluger P.T., Castaneda T.R., Neschen S., Hofmann S.M., et al. The central melanocortin system directly controls peripheral lipid metabolism. J. Clin. Invest. 117 (2007) 3475-3488
26. Obici S., Feng Z., Tan J., Liu L., Karkanias G., and Rossetti L. Central melanocortin receptors regulate insulin action. J. Clin. Invest. 108 (2001) 1079-1085
27. Perlemuter G., Bigorgne A., Cassard-Doulcier A.M., and Naveau S. Nonalcoholic fatty liver disease: from pathogenesis to patient care. Nat. Clin. Pract. Endocrinol. Metab. 3 (2007) 458-469
28. Petersen K.F., Dufour S., Savage D.B., Bilz S., Solomon G., Yonemitsu S., Cline G.W., Befroy D., Zemany L., Kahn B.B., et al. The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome. Proc. Natl. Acad. Sci. USA 104 (2007) 12587-12594
29. Reitman M.L. FGF21: a missing link in the biology of fasting. Cell Metab. 5 (2007) 405-407
30. Sampath H., and Ntambi J.M. Polyunsaturated fatty acid regulation of genes of lipid metabolism. Annu. Rev. Nutr. 25 (2005) 317-340
31. Scherer P.E. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 55 (2006) 1537-1545
32. Sharma A.M., and Staels B. Review: Peroxisome proliferator-activated receptor gamma and adipose tissue-understanding obesity-related changes in regulation of lipid and glucose metabolism. J. Clin. Endocrinol. Metab. 92 (2007) 386-395
33. Stayrook K.R., Rogers P.M., Savkur R.S., Wang Y., Su C., Varga G., Bu X., Wei T., Nagpal S., Liu X.S., et al. Regulation of human 3 alpha-hydroxysteroid dehydrogenase (AKR1C4) expression by the liver X receptor alpha. Mol. Pharmacol. 73 (2008) 607-612
34. Sutton G.M., Trevaskis J.L., Hulver M.W., McMillan R.P., Markward N.J., Babin M.J., Meyer E.A., and Butler A.A. Diet-genotype interactions in the development of the obese, insulin-resistant phenotype of C57BL/6J mice lacking melanocortin-3 or -4 receptors. Endocrinology 147 (2006) 2183-2196
35. Tinsley F.C., Taicher G.Z., and Heiman M.L. Evaluation of a quantitative magnetic resonance method for mouse whole body composition analysis. Obes. Res. 12 (2004) 150-160
36. Uyeda K., and Repa J.J. Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis. Cell Metab. 4 (2006) 107-110
37. Wang Y., Rogers P.M., Su C., Varga G., Stayrook K.R., and Burris T.P. Regulation of cholesterologenesis by the oxysterol receptor, LXRalpha. J. Biol. Chem. 283 (2008) 26332-26339
38. Zhou L., Sutton G.M., Rochford J.J., Semple R.K., Lam D.D., Oksanen L.J., Thornton-Jones Z.D., Clifton P.G., Yueh C.Y., Evans M.L., et al. Serotonin 2C receptor agonists improve type 2 diabetes via melanocortin-4 receptor signaling pathways. Cell Metab. 6 (2007) 398-405